| Schedule of accrued expenses and other current liabilities |
| | | | | | | | | June 30, | | December 31, | | | 2025 | | 2024 | Accrued licensee reimbursement | | | 295,711 | | | 295,711 | Accrued offering costs | | | 275,568 | | | — | Accrued rework of clinical supply returns | | | 250,000 | | | 250,000 | Accrued professional services | | | 196,730 | | | 111,750 | Accrued deposit for cancelled equipment orders | | | 162,066 | | | 162,066 | Accrued franchise tax | | | 100,000 | | | — | Accrued dividend | | | 97,167 | | | — | Accrued legal settlement | | | 75,000 | | | 100,000 | Other | | | 44,562 | | | 48,577 | Accrued compensation expense | | | — | | | 144,161 | Accrued fixed asset disposal costs | | | — | | | 125,000 | Accrued clinical studies costs | | | — | | | 85,409 | Total accrued expenses and other current liabilities | | $ | 1,496,804 | | $ | 1,322,674 |
|